Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus

被引:198
|
作者
Volarevic, Vladislav [1 ]
Arsenijevic, Nebojsa [1 ]
Lukic, Miodrag L. [1 ,2 ]
Stojkovic, Miodrag [1 ,3 ]
机构
[1] Univ Kragujevac, Ctr Mol Med, Fac Med, Kragujevac 34000, Serbia
[2] UAE Univ, Fac Med & Hlth Sci, Dept Microbiol & Immunol, Al Ain, U Arab Emirates
[3] Spebo Med, Leskovac 16000, Serbia
关键词
Mesenchymal stem cell; Cardiomyopathy; Nephropathy; Neuropathy; Wound; Diabetes mellitus; INSULIN-PRODUCING CELLS; MULTIPOTENT STROMAL CELLS; MURINE BONE-MARROW; IN-VITRO; GROWTH-FACTOR; HEART-RATE; RATS; MICE; DIFFERENTIATION; STREPTOZOTOCIN;
D O I
10.1002/stem.556
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stem cells (MSCs) are multipotent, self-renewing cells that can be found in almost all postnatal organs and tissues. The main functional characteristics of MSCs are their immunomodulatory ability, capacity for self-renewal, and differentiation into mesodermal tissues. The ability of MSCs to differentiate into several cell types, including muscle, brain, vascular, skin, cartilage, and bone cells, makes them attractive as therapeutic agents for a number of diseases including complications of diabetes mellitus. We review here the potential of MSCs as new therapeutic agents in the treatment of diabetic cardiomyopathy, diabetic nephropathy, diabetic polyneuropathy, diabetic retinopathy, and diabetic wounds. Also, in this review we discuss the current limitations for MSCs therapy in humans. STEM CELLS 2011;29:5-10
引用
收藏
页码:5 / 10
页数:6
相关论文
共 50 条
  • [1] Mesenchymal stem cell-based treatment for microvascular and secondary complications of Diabetes mellitus
    Davey, Grace C.
    Patil, Swapnil B.
    O'Loughlin, Aonghus
    O'Brien, Timothy
    FRONTIERS IN ENDOCRINOLOGY, 2014, 5
  • [2] Concise Review: Mesenchymal Stem Cells for Diabetes
    Dominguez-Bendala, Juan
    Lanzoni, Giacomo
    Inverardi, Luca
    Ricordi, Camillo
    STEM CELLS TRANSLATIONAL MEDICINE, 2012, 1 (01) : 59 - 63
  • [3] Concise Review: Mesenchymal Stem Cell Treatment for Ischemic Kidney Disease
    Zhu, Xiang-Yang
    Lerman, Amir
    Lerman, Lilach O.
    STEM CELLS, 2013, 31 (09) : 1731 - 1736
  • [4] Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
    Xiong, Jiachao
    Hu, Hao
    Guo, Rong
    Wang, Hui
    Jiang, Hua
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [5] Bone Marrow Derived Mesenchymal Stem Cells - A Boon for the Treatment of Complications in Diabetes Mellitus
    Pawar, Pratik M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2011, 1 (03): : 134 - 139
  • [6] Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: A concise review
    Wang, Ai-Tong
    Feng, Ying
    Jia, Hong-Hong
    Zhao, Meng
    Yu, Hao
    WORLD JOURNAL OF STEM CELLS, 2019, 11 (04): : 222 - 235
  • [7] The roles of mesenchymal stem cell-derived exosomes in diabetes mellitus and its related complications
    Yang, Mengmeng
    Chen, Jun
    Chen, Li
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [8] Mesenchymal stromal/stem cell separation methods: concise review
    Andreas Nicodemou
    Lubos Danisovic
    Cell and Tissue Banking, 2017, 18 : 443 - 460
  • [9] Mesenchymal stromal/stem cell separation methods: concise review
    Nicodemou, Andreas
    Danisovic, Lubos
    CELL AND TISSUE BANKING, 2017, 18 (04) : 443 - 460
  • [10] Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cells
    Paeth, Guenter
    Perakakis, Nikolaos
    Mantzoros, Christos S.
    Seufert, Jochen
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 90 : 1 - 15